Literature DB >> 20526437

Cortisol Response Following Exposure Treatment for PTSD in Rape Victims.

Maryrose Gerardi1, Barbara O Rothbaum, Millie C Astin, Mary Kelley.   

Abstract

This study examined changes in salivary cortisol levels pre-to-post-treatment in adult female rape victims diagnosed with post traumatic stress disorder (PTSD) randomly assigned to be treated with either Prolonged Exposure Therapy or Eye Movement Desensitization and Reprocessing. Salivary cortisol was collected at baseline, session 3, and session 9. A significant decrease in salivary cortisol levels was observed in individuals classified as treatment responders in both treatment conditions. Findings suggest that successful exposure-based treatments for PTSD which result in trauma-related and depressive symptom reduction may impact the action of the hypothalamic-pituitary-adrenal axis as measured by changes in level of salivary cortisol from pre-to-post-treatment.

Entities:  

Year:  2010        PMID: 20526437      PMCID: PMC2880549          DOI: 10.1080/10926771003781297

Source DB:  PubMed          Journal:  J Aggress Maltreat Trauma        ISSN: 1092-6771


  19 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse.

Authors:  M B Stein; R Yehuda; C Koverola; C Hanna
Journal:  Biol Psychiatry       Date:  1997-10-15       Impact factor: 13.382

Review 3.  Advances in understanding neuroendocrine alterations in PTSD and their therapeutic implications.

Authors:  Rachel Yehuda
Journal:  Ann N Y Acad Sci       Date:  2006-07       Impact factor: 5.691

4.  PTSD and the HPA axis: differences in response to the cold pressor task among individuals with child vs. adult trauma.

Authors:  Elizabeth J Santa Ana; Michael E Saladin; Sudie E Back; Angela E Waldrop; Eve G Spratt; Aimee L McRae; Steven D LaRowe; Mary Ann Timmerman; Himanshu Upadhyaya; Kathleen T Brady
Journal:  Psychoneuroendocrinology       Date:  2006-01-18       Impact factor: 4.905

5.  Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder.

Authors:  A M Rasmusson; D S Lipschitz; S Wang; S Hu; D Vojvoda; J D Bremner; S M Southwick; D S Charney
Journal:  Biol Psychiatry       Date:  2001-12-15       Impact factor: 13.382

6.  Integrating objective indicators of treatment outcome in posttraumatic stress disorder.

Authors:  M G Griffin; P Nishith; P A Resick; R Yehuda
Journal:  Ann N Y Acad Sci       Date:  1997-06-21       Impact factor: 5.691

7.  Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse.

Authors:  C Heim; D J Newport; R Bonsall; A H Miller; C B Nemeroff
Journal:  Am J Psychiatry       Date:  2001-04       Impact factor: 18.112

Review 8.  Current status of cortisol findings in post-traumatic stress disorder.

Authors:  Rachel Yehuda
Journal:  Psychiatr Clin North Am       Date:  2002-06

9.  Cortisol and catecholamines in posttraumatic stress disorder: an epidemiologic community study.

Authors:  Elizabeth A Young; Naomi Breslau
Journal:  Arch Gen Psychiatry       Date:  2004-04

10.  Urinary free-cortisol levels in posttraumatic stress disorder patients.

Authors:  J W Mason; E L Giller; T R Kosten; R B Ostroff; L Podd
Journal:  J Nerv Ment Dis       Date:  1986-03       Impact factor: 2.254

View more
  7 in total

1.  Glucocorticoid-related predictors and correlates of post-traumatic stress disorder treatment response in combat veterans.

Authors:  Rachel Yehuda; Laura C Pratchett; Matthew W Elmes; Amy Lehrner; Nikolaos P Daskalakis; Erin Koch; Iouri Makotkine; Janine D Flory; Linda M Bierer
Journal:  Interface Focus       Date:  2014-10-06       Impact factor: 3.906

2.  The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related Disorders.

Authors:  Michael L Sulkowski; Daniel A Geller; Adam B Lewin; Tanya K Murphy; Andrew Mittelman; Ashley Brown; Eric A Storch
Journal:  Curr Psychiatry Rev       Date:  2014

Review 3.  Cognitive enhancers for anxiety disorders.

Authors:  Stefan G Hofmann; Jasper A J Smits; Anu Asnaani; Cassidy A Gutner; Michael W Otto
Journal:  Pharmacol Biochem Behav       Date:  2010-12-04       Impact factor: 3.533

4.  The impact of PTSD treatment on the cortisol awakening response.

Authors:  Maria L Pacella; Norah Feeny; Lori Zoellner; Douglas L Delahanty
Journal:  Depress Anxiety       Date:  2014-10       Impact factor: 6.505

5.  Emergency department predictors of posttraumatic stress reduction for trauma-exposed individuals with and without an early intervention.

Authors:  Matthew Price; Megan Kearns; Debra Houry; Barbara O Rothbaum
Journal:  J Consult Clin Psychol       Date:  2014-02-03

Review 6.  Biological markers in clinical psychological research - A systematic framework applied to HPA axis regulation in PTSD.

Authors:  Sinha Engel; Hannah Klusmann; Sebastian Laufer; Claudia Kapp; Sarah Schumacher; Christine Knaevelsrud
Journal:  Compr Psychoneuroendocrinol       Date:  2022-06-09

Review 7.  Genes and hormones of the hypothalamic-pituitary-adrenal axis in post-traumatic stress disorder. What is their role in symptom expression and treatment response?

Authors:  Susanne Fischer; Tabea Schumacher; Christine Knaevelsrud; Ulrike Ehlert; Sarah Schumacher
Journal:  J Neural Transm (Vienna)       Date:  2021-04-07       Impact factor: 3.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.